Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids

British Journal of Nutrition

Volumn 108, Issue 8, 2012, Pages 1351-1359

  Kuang, Yu Lin ^a   Eric Paulson, K ^b   Lichtenstein, Alice H ^a   Lamon Fava, Stefania ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ApoA I; ATP binding cassette A1; Fatty acids; HDL; HepG2

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; LIVER X RECEPTOR; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; UNSATURATED FATTY ACID;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; LIPOPROTEIN METABOLISM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

APOLIPOPROTEIN A-I; ARACHIDONIC ACID; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL, HDL; DIET; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HEP G2 CELLS; HUMANS; MEDIATOR COMPLEX SUBUNIT 1; ORPHAN NUCLEAR RECEPTORS; PALMITIC ACID; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEINS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84867691068     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006854     Document Type: Article

References (62)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, e46-e215.
2. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
3. Fielding CJ & Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36, 211-228.
4. Lewis GF & Rader DJ (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96, 1221-1232.
5. Shah PK, Kaul S, Nilsson J, et al. (2001) Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II. Circulation 104, 2498-2502.
6. Oram JF & Vaughan AM (2000) ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 11, 253-260.
7. Timmins JM, Lee JY, Boudyguina E, et al. (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 115, 1333-1342.
8. Jonas A (2000) Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529, 245-256.
9. Masson D, Jiang XC, Lagrost L, et al. (2009) The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. J Lipid Res 50, S201-S206.
10. Shirai K, Barnhart RL & Jackson RL (1981) Hydrolysis of human plasma high density lipoprotein 2-phospholipids and triglycerides by hepatic lipase. Biochem Biophys Res Commun 100, 591-599.
11. Lambert G, Chase MB, Dugi K, et al. (1999) Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J Lipid Res 40, 1294-1303.
12. Acton S, Rigotti A, Landschulz KT, et al. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518-520.
13. Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet ii, 757-761.
14. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354, 447-455.
15. Lamon-Fava S, Ordovas JM & Schaefer EJ (1999) Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 19, 2960-2965.
16. Allred CD, Talbert DR, Southard RC, et al. (2008) PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 138, 250-256.
17. Willy PJ, Umesono K, Ong ES, et al. (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9, 1033-1045.
18. Sampath H & Ntambi JM (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25, 317-340.
19. Sorci-Thomas M, Prack MM, Dashti N, et al. (1989) Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res 30, 1397-1403.
20. Abbey M, Clifton P, Kestin M, et al. (1990) Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 10, 85-94.
21. Berthou L, Saladin R, Yaqoob P, et al. (1995) Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acylcoenzyme A oxidase gene expression by fibrates and dietary fatty acids. Eur J Biochem 232, 179-187.
22. Brousseau ME, Ordovas JM, Osada J, et al. (1995) Dietary monounsaturated and polyunsaturated fatty acids are comparable in their effects on hepatic apolipoprotein mRNA abundance and liver lipid concentrations when substituted for saturated fatty acids in cynomolgus monkeys. J Nutr 125, 425-436.
23. Lagrost L, Mensink RP, Guyard-Dangremont V, et al. (1999) Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis 142, 395-402.
24. Spady DK, Kearney DM & Hobbs HH (1999) Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res 40, 1384-1394.
25. Frenais R, Ouguerram K, Maugeais C, et al. (2001) Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus. Atherosclerosis 157, 131-135.
26. le Morvan V, Dumon MF, Palos-Pinto A, et al. (2002) n-3 FA increase liver uptake of HDL-cholesterol in mice. Lipids 37, 767-772.
27. Hatahet W, Cole L, Kudchodkar BJ, et al. (2003) Dietary fats differentially modulate the expression of lecithin:cholesterol acyltransferase, apoprotein-A1 and scavenger receptor b1 in rats. J Nutr 133, 689-694.
28. Morgado N, Rigotti A & Valenzuela A (2005) Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat. Ann Nutr Metab 49, 397-406.
29. Chan DC, Watts GF, Nguyen MN, et al. (2006) Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr 84, 37-43.
30. Sjogren P, Rosell M, Skoglund-Andersson C, et al. (2004) Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. J Nutr 134, 1729-1735.
31. Magkos F, Patterson BW, Mohammed BS, et al. (2007) Womenproduce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab 92, 1311-1318.
32. Conquer JA & Holub BJ (1998) Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J Lipid Res 39, 286-292.
33. Spector AA (2001) Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci 16, 159-165, discussion 215-121.
34. Zehethofer N, Pinto DM & Volmer DA (2008) Plasma free fatty acid profiling in a fish oil human intervention study using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 22, 2125-2133.
35. Bragt MC & Mensink RP (2011) Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects. Nutr Metab Cardiovasc Dis (epublication ahead of print version 21 March 2011).
36. Khosla P & Sundram K (1996) Effects of dietary fatty acid composition on plasma cholesterol. Prog Lipid Res 35, 93-132.
37. Skeaff CM, Hodson L & McKenzie JE (2006) Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr 136, 565-569.
38. Matthan NR, Welty FK, Barrett PH, et al. (2004) Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol 24, 1092-1097.
39. Vu-Dac N, Schoonjans K, Laine B, et al. (1994) Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 269, 31012-31018.
40. Berthou L, Duverger N, Emmanuel F, et al. (1996) Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J Clin Invest 97, 2408-2416.
41. Kuang YL, Paulson KE, Lichtenstein AH, et al. (2011) Docosahexaenoic acid suppresses apolipoprotein A-I gene expression through hepatocyte nuclear factor-3 {beta}. Am J Clin Nutr 94, 594-600.
42. Alvaro A, Rosales R, Masana L, et al. (2010) Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem 21, 518-525.
43. Uehara Y, Engel T, Li Z, et al. (2002) Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 51, 2922-2928.
44. Costet P, Luo Y, Wang N, et al. (2000) Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275, 28240-28245.
45. Schwartz K, Lawn RM & Wade DP (2000) ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274, 794-802.
46. Uehara Y, Miura S, von Eckardstein A, et al. (2007) Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 191, 11-21.
47. Ou J, Tu H, Shan B, et al. (2001) Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing liganddependent activation of the LXR. Proc Natl Acad Sci USA 98, 6027-6032.
48. Wang Y & Oram JF (2002) Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 277, 5692-5697.
49. Wang Y & Oram JF (2005) Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem 280, 35896-35903.
50. Wang Y & Oram JF (2007) Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res 48, 1062-1068.
51. Yang Y, Jiang Y, Wang Y, et al. (2010) Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 92, 958-963.
52. Fungwe TV, Kudchodkar BJ, Lacko AG, et al. (1998) Fatty acids modulate lecithin:cholesterol acyltransferase secretion independently of effects on triglyceride secretion in primary rat hepatocytes. J Nutr 128, 1270-1275.
53. Laffitte BA, Joseph SB, Chen M, et al. (2003) The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol 23, 2182-2191.
54. Tu AY & Albers JJ (1999) DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Biochem Biophys Res Commun 264, 802-807.
55. Lecker JL, Matthan NR, Billheimer JT, et al. (2010) Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1B hamster. Metabolism 59, 1491-1501.
56. Hirano R, Igarashi O, Kondo K, et al. (2001) Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells. Lipids 36, 401-406.
57. Asztalos Bela F & Brunzell J (2010) The kinetics and remodeling of HDL particles: lessons from inborn errors of lipid metabolism. In High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease, 1st ed., pp. 33-44 [EJ Schaefer, editor]. New York: Springer.
58. Davidson MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27i-33i.
59. Nishimoto T, Pellizzon MA, Aihara M, et al. (2009) Fish oil promotes macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol 29, 1502-1508.
60. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30.
61. Russo GL (2009) Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77, 937-946.
62. Norata GD, Ongari M, Uboldi P, et al. (2005) Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. Int J Mol Med 16, 717-722.